During this time he led the science and business strategy of the company and took Devgen public on Euronext in 2005.
Building on genetics as its core scientific strength, He developed Devgen into a leading provider of new crop protection technologies to the Agro industry and an Asian seed company that fundamentally redesigned Hybrid Rice delivering a pipeline of high yielding products for Indian and South East Asian markets.
Prior to its sale to Syngenta, Devgen seeds were produced on >8000 ha and sold in ~20,000 retail shops across India, Indonesia and Philippines.
He obtained a PhD at the Laboratory of Molecular Biology, Medical Research Council, (Cambridge, United Kingdom).
His research interest was about Drosophila melanogaster integrins[1][2] and a Caenorhabditis elegans UNC gene (uncoordinated phenotype).